INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

JACOBS LEVY EQUITY MANAGEMENT, INC's Holding History (CIK: 0000884414)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 861,801 Value ($000) $9,532 Avg Close — Range —
Q1 2023
Shares 923,369 Value ($000) $12,401 Avg Close — Range —
Q4 2022
Shares 923,107 Value ($000) $11,419 Avg Close — Range —
Q3 2022
Shares 780,945 Value ($000) $10,894 Avg Close — Range —
Q2 2022
Shares 645,691 Value ($000) $8,917 Avg Close — Range —
Q1 2022
Shares 592,304 Value ($000) $9,637 Avg Close — Range —
Q4 2021
Shares 588,922 Value ($000) $9,594 Avg Close — Range —
Q3 2021
Shares 534,176 Value ($000) $7,933 Avg Close — Range —
Q2 2021
Shares 613,888 Value ($000) $12,259 Avg Close — Range —
Q1 2021
Shares 532,102 Value ($000) $12,281 Avg Close — Range —
Q4 2020
Shares 479,724 Value ($000) $11,849 Avg Close — Range —
Q3 2020
Shares 347,246 Value ($000) $14,397 Avg Close — Range —
Q2 2020
Shares 49,457 Value ($000) $2,369 Avg Close — Range —
Q1 2020
Shares 44,002 Value ($000) $2,770 Avg Close — Range —
Q4 2019
Shares 44,342 Value ($000) $5,495 Avg Close — Range —
Q3 2019
Shares 40,292 Value ($000) $2,674 Avg Close — Range —
Q2 2016
Shares 8,120 Value ($000) $1,159 Avg Close — Range —
Q1 2016
Shares 13,040 Value ($000) $1,675 Avg Close — Range —